Testing effectiveness (Phase 2)UnknownNCT03917069What this trial is testingNab-PCE vs PC for MM After Failure of Anti-PD-1Who this might be right forAdvanced Melanoma Peking University Cancer Hospital & Institute 145
Early research (Phase 1)UnknownNCT04665362What this trial is testingIIT Study of M1-c6v1 Combined With SHR-1210 and Apatinib in Patients With HCCWho this might be right forAdvanced/Metastatic Hepatocellular Carcinoma Liang Peng 10
Large-scale testing (Phase 3)Active Not RecruitingNCT04579224What this trial is testingComparing the New Anti-cancer Drug Eribulin With Chemotherapy Against the Usual Chemotherapy Alone in Metastatic Urothelial CancerWho this might be right forMetastatic Bladder Urothelial CarcinomaMetastatic Urothelial CarcinomaRefractory Bladder Urothelial Carcinoma+2 more National Cancer Institute (NCI) 184
Early research (Phase 1)Looking for participantsNCT05741359What this trial is testingThe Safety and Efficacy of BRL-201 in the Treatment of r/r B Lymphocyte Non-Hodgkin LymphomaWho this might be right forNon-hodgkin Lymphoma,B Cell Bioray Laboratories 18
Testing effectiveness (Phase 2)Looking for participantsNCT05628922What this trial is testingModulation Therapy for Locally Advanced NPC Based on Plasma EBV DNA Level Post-ICTWho this might be right forNasopharyngeal Cancer Fudan University 198
Testing effectiveness (Phase 2)Looking for participantsNCT06471205What this trial is testingBL-B01D1+PD-1 Monoclonal Antibody in Patients With Unresectable Locally Advanced or Recurrent Metastatic Triple-negative Breast CancerWho this might be right forTriple-negative Breast Cancer Sichuan Baili Pharmaceutical Co., Ltd. 52
Testing effectiveness (Phase 2)UnknownNCT05218629What this trial is testingAnlotinib Plus PD-1 Inhibitor as 2nd-line Threapy in Patients With Metastatic Pancreatic CancerWho this might be right forOverall Survival Qingdao Central Hospital 20
Testing effectiveness (Phase 2)Ended earlyNCT03799445What this trial is testingIpilimumab, Nivolumab, and Radiation Therapy in Treating Patients With HPV Positive Advanced Oropharyngeal Squamous Cell CarcinomaWho this might be right forClinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma+8 more M.D. Anderson Cancer Center
Large-scale testing (Phase 3)Looking for participantsNCT05754853What this trial is testingMRG002 Versus Investigator's Choice of Chemotherapy in the Treatment of Patients With HER2-positive Unresectable Advanced or Metastatic Urothelial CancerWho this might be right forAdvanced or Metastatic Urothelium Cancer Shanghai Miracogen Inc. 290
Not applicableLooking for participantsNCT06613165What this trial is testingExploring the Treatment Duration of PD-1 Neoadjuvant Therapy in Stage II-III dMMR Rectal CancerWho this might be right forImmune-related Adverse EventNeoadjuvant TherapydMMR Colorectal Cancer Xijing Hospital 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT04729322What this trial is testingFecal Microbiota Transplant and Re-introduction of Anti-PD-1 Therapy (Pembrolizumab or Nivolumab) for the Treatment of Metastatic Colorectal Cancer in Anti-PD-1 Non-respondersWho this might be right forMetastatic Colorectal AdenocarcinomaMetastatic Small Intestinal AdenocarcinomaStage IV Colorectal Cancer AJCC v8+4 more M.D. Anderson Cancer Center 15
Testing effectiveness (Phase 2)Study completedNCT04799639What this trial is testingEfficacy and Toxicity of Paclitaxel, Cisplatin Combined With Sindilimab in NACT for Locally Advanced Cervical CancerWho this might be right forCervical CancerChemotherapy EffectProgrammed Cell Death 1 Receptor / Antagonists & Inhibitors+1 more Sun Yat-sen University 47
Not applicableUnknownNCT03787953What this trial is testingA Real World Study of Anti-PD-1/PD-L1 Antibodies for the Treatment of Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors Chinese PLA General Hospital 400
Testing effectiveness (Phase 2)UnknownNCT03904537What this trial is testingCombination of Anti-PD1 Antibody-activated TILs and Chemotherapy in Colorectal CancerWho this might be right forColorectal Cancer Stage III Sun Yat-sen University 20
Testing effectiveness (Phase 2)Looking for participantsNCT05932212What this trial is testingAK104 for Recurrent or Metastatic Vulvar CancerWho this might be right forVulvar Cancer Akeso 20
Testing effectiveness (Phase 2)Looking for participantsNCT07213934What this trial is testingPhase I/ II Trial Combining PD-1 Inhibition and Neoadjuvant Proton or Photon Radiation Therapy in Recurrent Head and Neck Squamous Cell CarcinomaWho this might be right forHead and Neck CancerRecurrent Head and Neck Squamous Cell Carcinoma University of Cincinnati 40
Not applicableUnknownNCT04174339What this trial is testingPD-1 Antibody(SHR-1210) Plus Apatinib Combined With POF in Advanced Gastric CancerWho this might be right forAdvanced Gastric Adenocarcinoma Fujian Cancer Hospital 20
Testing effectiveness (Phase 2)UnknownNCT05095636What this trial is testingApatinib Monotherapy Versus Apatinib Combined With Camrelizumab for Third-line Treatment of Metastatic Gastric CancerWho this might be right forGastric CancerMetastasis Fudan University 102
Testing effectiveness (Phase 2)Study completedNCT03029598What this trial is testingPembrolizumab and Carboplatin in Treating Patients With Relapsed or Refractory Ovarian, Fallopian Tube, or Primary Peritoneal CancerWho this might be right forRecurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal Carcinoma University of Washington 29
Testing effectiveness (Phase 2)Looking for participantsNCT05284539What this trial is testingEfficacy of Platinum-based Chemotherapy Plus Immune Checkpoint Inhibitors for EGFR/ALK/ROS1 Mutant Lung CancerWho this might be right forNon Small Cell Lung Cancer Hunan Province Tumor Hospital 760